Polydrug Lands FDA Warning Letter on Post-ban Data Integrity Claims
The FDA has slapped Polydrug Laboratories’ Mumbai facility with a warning letter for alleged GMP deviations seven months after it received a ban on U.S. imports.
Source: Drug GMP Report